Symptomatic conduction system disease in cardiac amyloidosis

Am J Cardiol. 1997 Dec 1;80(11):1491-2. doi: 10.1016/s0002-9149(97)82785-3.

Abstract

Symptomatic conduction system disease in cardiac amyloidosis and its management has been reported infrequently. We report our experience of patients with amyloidosis having symptomatic conduction system disease requiring permanent pacemaker implantation.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Amyloidosis / complications*
  • Amyloidosis / mortality
  • Amyloidosis / therapy
  • Arrhythmias, Cardiac / etiology*
  • Arrhythmias, Cardiac / mortality
  • Arrhythmias, Cardiac / therapy
  • Cardiac Pacing, Artificial / adverse effects
  • Cardiac Pacing, Artificial / methods
  • Cardiomyopathies / complications*
  • Cardiomyopathies / mortality
  • Cardiomyopathies / therapy
  • Defibrillators, Implantable / adverse effects
  • Female
  • Follow-Up Studies
  • Heart Conduction System / physiopathology*
  • Humans
  • Male
  • Survival Rate
  • Treatment Outcome